Compounds > pyrazines
Page last updated: 2024-08-21

pyrazines and Telangiectasis

pyrazines has been researched along with Telangiectasis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bastani, B; Fesler, M; Jasim, S; Mahmud, G1
O'Connell, C; Schroyens, W; Sykes, DB2
Korde, N; Kwok, M; Landgren, O1

Other Studies

4 other study(ies) available for pyrazines and Telangiectasis

ArticleYear
Subcutaneous bortezomib for treatment of TEMPI syndrome.
    Clinical lymphoma, myeloma & leukemia, 2014, Volume: 14, Issue:6

    Topics: Boronic Acids; Bortezomib; Edema; Female; Humans; Middle Aged; Paraproteinemias; Polycythemia; Proteasome Inhibitors; Pyrazines; Skin; Telangiectasis; Treatment Outcome

2014
The TEMPI syndrome--a novel multisystem disease.
    The New England journal of medicine, 2011, Aug-04, Volume: 365, Issue:5

    Topics: Adult; Boronic Acids; Bortezomib; Erythropoietin; Female; Humans; Hydronephrosis; Lymphangiectasis; Male; Middle Aged; Paraproteinemias; Polycythemia; Protease Inhibitors; Pyrazines; Syndrome; Telangiectasis

2011
Bortezomib to treat the TEMPI syndrome.
    The New England journal of medicine, 2012, May-10, Volume: 366, Issue:19

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Erythropoietin; Female; Humans; Lymphangiectasis; Middle Aged; Paraproteinemias; Polycythemia; Pyrazines; Syndrome; Telangiectasis

2012
Complete and partial responses of the TEMPI syndrome to bortezomib.
    The New England journal of medicine, 2012, Aug-23, Volume: 367, Issue:8

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Erythropoietin; Female; Humans; Male; Middle Aged; Paraproteinemias; Polycythemia; Pyrazines; Syndrome; Telangiectasis

2012